Try our Advanced Search for more refined results
March 10, 2015
Khoja et al v. Orexigen Therapeutics, Inc. et al
Case Number:
3:15-cv-00540
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 23, 2021
Pharma Co.'s $4.8M Investor Deal OK'd, But Fees Undecided
A California federal judge on Thursday preliminarily granted a $4.8 million proposed settlement to resolve allegations that Orexigen Therapeutics had a duty to warn investors after learning a drug wasn't as beneficial as earlier data indicated, but questioned class counsel's requested amount in attorney fees.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login